Share on LinkedInShare on LinkedIn

ARTICLE · 28 JANUARY 2019

Supreme Court Issues Decision In Helsinn v. Teva

On January 22, 2019, the Supreme Court issued a decision in Helsinn Healthcare S.A. et al. v. Teva Pharmaceuticals USA, Inc., No. 17-1229. The Supreme Court unanimously held that the America Invents

United StatesIntellectual Property

On January 22, 2019, the Supreme Court issued a decision in Helsinn Healthcare S.A. et al. v. Teva Pharmaceuticals USA, Inc., No. 17-1229. The Supreme Court unanimously held that the America Invents Act (AIA) on-sale bar, like the pre-AIA on-sale bar, extends to "secret sales."

Background

Under pre-AIA law, a sale or offer for sale of an invention—including an inventor's "secret" sales to a third party that is required to keep the invention confidential—could act as a bar to patentability. The AIA retained the pre-AIA "on sale" terminology but added the catch-all phrase "or otherwise available to the public." The US Patent and Trademark Office (USPTO) subsequently issued guidelines explaining that the AIA on-sale bar does not cover "secret sales" and explained that activities are "secret" if they are among individuals having an obligation of confidentiality to the inventor. The district court that decided the Helsinn case initially applied the

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from